Get started
Author

Iris A.S. Stroot

Observed names: I Stroot, Iris A S Stroot, Iris A. S. Stroot, Iris Stroot, Stroot, I., Stroot, Iris A S
ORCID: 0000-0002-5506-8841
Observed ORCID: 0000-0002-5506-8841
OpenAlex ID: A5016817648
High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors
2023 · Iris A.S. Stroot, Jan Brouwer, et al. · Journal of Clinical Oncology · 15
PDF
Reliability, costs, and radiation dose of dual-energy X-ray absorptiometry in diagnosis of radiologic sarcopenia in surgically menopausal women
2024 · Annechien Stuursma, Iris A. S. Stroot, et al. · Insights into Imaging · 9
PDF
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers
2024 · Iris A S Stroot, Joost Bart, et al. · JNCI Journal of the National Cancer Institute · 5
PDF
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers
2024 · Iris A.S. Stroot, Joost Bart, et al. · Gynecologic Oncology · 2
Serous Tubal Intraepithelial Carcinoma After Neoadjuvant Chemotherapy: A Report of 2 Cases
2024 · Iris A.S. Stroot, Leonie Smit, et al. · International Journal of Gynecological Pathology · 1
999 Significance of complete embedding of risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers
2024 · Iris A.S. Stroot, Geertruida HDe Bock, et al. · International Journal of Gynecological Cancer
1002 Incidence of peritoneal high-grade serous carcinoma after normal risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers
2024 · Iris A.S. Stroot, Joost Bart, et al. · International Journal of Gynecological Cancer
EP185/#391 Role of extensive processing of risk-reducing salpingo-oophorectomy specimens in BRCA1/2 germline pathogenic variant carriers
2022 · Iris Stroot, J.a.n. Brouwer, et al. · International Journal of Gynecological Cancer
PDF
EP173/#392 High-grade serous carcinoma in risk-reducing salpingo-oophorectomy specimens of asymptomatic carriers of a BRCA1/2 germline pathogenic variant
2022 · Iris Stroot, J.a.n. Brouwer, et al. · International Journal of Gynecological Cancer
PDF
EPV153/#66 Reliability, costs and applicability of the whole body dexa scan in the assessment of muscle mass after risk-reducing salpingo-oophorectomy in brca1/2 PV carriers
2021 · I Stroot, A Stuursma, et al. · E-Posters
PDF
Works count: 12
Citation count: 32
H-index: 3
I10-index: 1
Year
Topic
Type